4.5 Article

Mutation analysis of VCP in British familial and sporadic amyotrophic lateral sclerosis patients

Journal

NEUROBIOLOGY OF AGING
Volume 33, Issue 11, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2012.06.003

Keywords

Amyotrophic lateral sclerosis; Motor neuron disease; Familial ALS; VCP gene; Mutation

Funding

  1. Medical Research Council
  2. Motor Neuron Disease Association (UK)
  3. American ALS Association
  4. Heaton-Ellis Trust
  5. European Community [259867]
  6. MRC [G0500289, MC_G1000733, G0900688] Funding Source: UKRI
  7. Medical Research Council [G0500289B, G0900688, MC_G1000733, G0500289] Funding Source: researchfish

Ask authors/readers for more resources

Mutations in the valosin-containing-protein (VCP) gene are associated with the multidisorder disease, inclusion body myopathy with Pagets and associated frontotemporal dementia. This disease is characterized pathologically by large ubiquitinated, TAR DNA Binding Protein 43 (TDP-43) positive inclusions. These inclusions are also a common feature in neurological diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTLD). Mutations in the VCP gene have been identified in ALS patients, therefore we aimed to characterize VCP variations in our own cohort of familial and sporadic ALS patients by sequencing all 17 coding exons of VCP. This study failed to detect any exonic variations in a subset of British familial and sporadic ALS patients. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available